Glucag0n
Product Images NDC 51662-1323
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Glucag0n (NDC 51662-1323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Clinical B (Clinical Pharma B)
Dosage (Dosage Table)
Image 1 (Ifu 1)
Image 2 (Ifu 2)
Image 3 (Ifu 3)
Image 4 (Ifu 4)
Table 1 (Ifu Table 1)
This text describes various symptoms related to a medical condition, including sweating, drowsiness, dizziness, sleep disturbances, palpitation, anxiety, tremor, blurred vision, hunger, slurred speech, restlessness, depressed mood, tingling in the hands, feet, lips, or tongue, irritability, lightheadedness, abnormal behavior, inability to concentrate, unsteady movement, headache, and personality changes.*
Table 2 (Ifu Table 2)
Label 1 (Label 1)
The text describes a Glucagon Emergency Kit with product details and manufacturing locations. The kit includes Glucagon for Injection, which is prescribed for low blood sugar. The diluting syringe is manufactured in Germany. Therefore, it is a medication used in emergency situations to increase blood sugar levels.*
Label 2 (Label 2)
Serialized Label (Serialized Label)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.